Eli Lilly and Company is a leading innovation-driven corporation committed to developing a growing portfolio of first-in-class and best-in-class pharmaceutical products that help people live longer, healthier and more active lives. Lilly products treat depression, schizophrenia, attention-deficit hyperactivity disorder, diabetes, osteoporosis and many other conditions.

Elanco Animal Health, a division of Eli Lilly and Company, is a global research-based company that develops and markets products to improve the health and production of animals in more than 100 countries. Elanco is committed to production animals. Elanco products enhance animal health, wellness and performance to help the food industry produce an abundant supply of safe and affordable food.